Apnea Hypopnea Index Severity Versus Head Position During Sleep
The Effect of Head Pitch and Roll Rotation Independent of Torso Rotation on the AHI in Positional Obstructive Sleep Apnea
1 other identifier
interventional
8
1 country
1
Brief Summary
This study evaluates the correlation of the position of the head during sleep, independent of the position of the torso, and the severity of apnea hypopneas in obstructive sleep apnea.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 28, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 19, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2017
CompletedFirst Submitted
Initial submission to the registry
August 29, 2019
CompletedFirst Posted
Study publicly available on registry
September 11, 2019
CompletedResults Posted
Study results publicly available
June 30, 2020
CompletedJune 30, 2020
June 1, 2020
12 months
August 29, 2019
September 24, 2019
June 16, 2020
Conditions
Outcome Measures
Primary Outcomes (4)
Number of Participants With Apnea Hypopnea Index (AHI) Severity Improvement
Investigators will perform a standard polysomnography with the addition of a precision forehead mounted angular sensor and monitor the severity of apnea hypopnea index (AHI) for the total time duration spent sleeping in each head position. The key measurement is the subjects' relative improvement in AHI with the head supine (45⁰ to 135⁰) as compared to non-supine (\<20⁰above the horizon)
8 hour polysomnography study with subjects being assessed at each head pitch and roll angle epoch
Number of Participants With SpO2 Desaturation Severity Improvement
Investigators will perform a standard polysomnography with the addition of a precision forehead mounted angular sensor and monitor the severity of SpO2 desaturation for the total time duration spent sleeping in each head position. The key measurement is the subjects' relative improvement in SpO2 de-saturation with the head supine (45⁰ to 135⁰) as compared to non-supine (\<20⁰above the horizon)
8 hour polysomnography study with subjects being assessed at each head pitch and roll angle epoch
Number of Participants With Improvement Independent of Torso Using Forehead Mounted Pitch and Roll Angle Sensor
Investigators will perform a standard polysomnography with the addition of a precision forehead mounted angular sensor and monitor the severity of apnea hypopnea index (AHI) as subjects sleep with the torso in the supine position while the head is ≤ 20⁰ and with the torso in the non-supine position while the head is above 45 degrees. The key measurement is the subjects' relative improvement in AHI with the head supine (45⁰ to 135⁰) as compared to non-supine (\<20⁰above the horizon) independent of torso position
8 hour polysomnography study with subjects being assessed at each head pitch and roll angle epoch
Torso Independent With SpO2 Improvement Using Forehead Mounted Pitch and Roll Angle Sensor
Investigators will perform a standard polysomnography with the addition of a precision forehead mounted angular sensor and monitor the severity of SpO2 desaturation as subjects sleep with the torso in the supine position while the head is ≤ 20⁰ and with the torso in the non-supine position while the head is above 45 degrees. The key measurement is the subjects' relative improvement in SpO2 desaturation with the head supine (45⁰ to 135⁰) as compared to non-supine (\<20⁰above the horizon) independent of torso position
8 hour polysomnography study with subjects being assessed at each head pitch and roll angle epoch
Study Arms (1)
Forehead sensor recording precision head pitch and roll angle
EXPERIMENTALDuring an overnight polysomnography, participants were coached by sleep research technologists to sleep with their head in positions hypothesized to minimize apnea severity ≤20⁰ or ≥160⁰, and those hypothesized to maximize apnea severity between 30⁰ and 150⁰. Head roll angles were measured and recorded by the participant's forehead sensor attached with adhesive and tape. Extreme head positions were attempted with the torso in both supine and non-supine positions so show insensitivity to torso position. A custom interface was developed to maintain compatibility with specific bedside polysomnography recorder auxiliary inputs. Sleep epochs were considered those where the subject slept for at least 10 minutes. Each head position epoch was analyzed for apnea hypopnea index and oxygen desaturation.
Interventions
This is the first clinical trial in the industry to address OSA symptom severity and snoring as a direct function of head pitch and roll angle. The head pitch and roll angle can be used with high consistency to predict OSA symptom severity. The apnea equation is based on the gravitational crush forces of the mass of the tongue and nearby tissue on the upper air way and is valid for most OSA sufferers.
Eligibility Criteria
You may qualify if:
- Participant has provided written informed consent
- Participant is diagnosed with Positional Obstructive Sleep Apnea
- Participant age is between 21 and 60 years
- If currently on Positive Air Pressure (PAP) therapy, is able to produce compliance data within the last week before screening visit
- Is able to follow directions during the overnight sleep study
- If currently on PAP therapy participant self-report that excessive daytime sleepiness persists when PAP therapy is not in use
- Able to be of "PAP" therapy for 4 nights
You may not qualify if:
- Documented diagnosis of Insomnia
- Chronic ear infections
- Persistent neck "pains"
- Persistent chronic posture physical issues
- Previous C-Spine fusion
- History of Cardiac Arrythmia
- History of seizures
- Allergic to Standard Tape used in Sleep Centers
- Non-English speaking.
- Hospitalization within the previous 4 weeks
- Use of antibiotics or steroids within the previous 4 weeks
- Any major uncontrolled disease or condition, such as congestive heart failure, malignancy, end-stage heart disease, end-stage heart disease. Arterial Laterial Sclerosis (ALS), or sever stroke, or other condition as deemed appropriate by investigator as determined by review of medical history and/or participant reported medical history
- History of severe osteoporosis
- Excessive alcohol intake (\> 6oz hard liquor, 48 oz beer or 20 oz wine daily), or illicit drug use by review of medical history and/or participant reported medical history
- Daily use of prescribed narcotics (greater than 30 mg morphine equivalent)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sleep Systemslead
- New England IRBcollaborator
- Mass Lung and Allergy, PCcollaborator
Study Sites (1)
Mass Lung and Allergy
Worcester, Massachusetts, 01605, United States
Related Publications (19)
Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc. 2008 Feb 15;5(2):136-43. doi: 10.1513/pats.200709-155MG.
PMID: 18250205BACKGROUNDPark JG, Ramar K, Olson EJ. Updates on definition, consequences, and management of obstructive sleep apnea. Mayo Clin Proc. 2011 Jun;86(6):549-54; quiz 554-5. doi: 10.4065/mcp.2010.0810.
PMID: 21628617BACKGROUNDRavesloot MJ, van Maanen JP, Dun L, de Vries N. The undervalued potential of positional therapy in position-dependent snoring and obstructive sleep apnea-a review of the literature. Sleep Breath. 2013 Mar;17(1):39-49. doi: 10.1007/s11325-012-0683-5. Epub 2012 Mar 24.
PMID: 22441662BACKGROUNDEpstein LJ, Kristo D, Strollo PJ Jr, Friedman N, Malhotra A, Patil SP, Ramar K, Rogers R, Schwab RJ, Weaver EM, Weinstein MD; Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009 Jun 15;5(3):263-76.
PMID: 19960649BACKGROUNDMador MJ, Kufel TJ, Magalang UJ, Rajesh SK, Watwe V, Grant BJ. Prevalence of positional sleep apnea in patients undergoing polysomnography. Chest. 2005 Oct;128(4):2130-7. doi: 10.1378/chest.128.4.2130.
PMID: 16236865BACKGROUNDCartwright R, Ristanovic R, Diaz F, Caldarelli D, Alder G. A comparative study of treatments for positional sleep apnea. Sleep. 1991 Dec;14(6):546-52. doi: 10.1093/sleep/14.6.546.
PMID: 1798889BACKGROUNDCartwright RD, Lloyd S, Lilie J, Kravitz H. Sleep position training as treatment for sleep apnea syndrome: a preliminary study. Sleep. 1985;8(2):87-94. doi: 10.1093/sleep/8.2.87.
PMID: 4012159BACKGROUNDJokic R, Klimaszewski A, Crossley M, Sridhar G, Fitzpatrick MF. Positional treatment vs continuous positive airway pressure in patients with positional obstructive sleep apnea syndrome. Chest. 1999 Mar;115(3):771-81. doi: 10.1378/chest.115.3.771.
PMID: 10084491BACKGROUNDPermut I, Diaz-Abad M, Chatila W, Crocetti J, Gaughan JP, D'Alonzo GE, Krachman SL. Comparison of positional therapy to CPAP in patients with positional obstructive sleep apnea. J Clin Sleep Med. 2010 Jun 15;6(3):238-43.
PMID: 20572416BACKGROUNDEijsvogel MM, Ubbink R, Dekker J, Oppersma E, de Jongh FH, van der Palen J, Brusse-Keizer MG. Sleep position trainer versus tennis ball technique in positional obstructive sleep apnea syndrome. J Clin Sleep Med. 2015 Jan 15;11(2):139-47. doi: 10.5664/jcsm.4460.
PMID: 25515276BACKGROUNDBignold JJ, Mercer JD, Antic NA, McEvoy RD, Catcheside PG. Accurate position monitoring and improved supine-dependent obstructive sleep apnea with a new position recording and supine avoidance device. J Clin Sleep Med. 2011 Aug 15;7(4):376-83. doi: 10.5664/JCSM.1194.
PMID: 21897774BACKGROUNDvan Maanen JP, Richard W, Van Kesteren ER, Ravesloot MJ, Laman DM, Hilgevoord AA, de Vries N. Evaluation of a new simple treatment for positional sleep apnoea patients. J Sleep Res. 2012 Jun;21(3):322-9. doi: 10.1111/j.1365-2869.2011.00974.x. Epub 2011 Oct 22.
PMID: 22017727BACKGROUNDLevendowski DJ, Seagraves S, Popovic D, Westbrook PR. Assessment of a neck-based treatment and monitoring device for positional obstructive sleep apnea. J Clin Sleep Med. 2014 Aug 15;10(8):863-71. doi: 10.5664/jcsm.3956.
PMID: 25126032BACKGROUNDRavesloot MJL, White D, Heinzer R, Oksenberg A, Pepin JL. Efficacy of the New Generation of Devices for Positional Therapy for Patients With Positional Obstructive Sleep Apnea: A Systematic Review of the Literature and Meta-Analysis. J Clin Sleep Med. 2017 Jun 15;13(6):813-824. doi: 10.5664/jcsm.6622.
PMID: 28212691BACKGROUNDvan Kesteren ER, van Maanen JP, Hilgevoord AA, Laman DM, de Vries N. Quantitative effects of trunk and head position on the apnea hypopnea index in obstructive sleep apnea. Sleep. 2011 Aug 1;34(8):1075-81. doi: 10.5665/SLEEP.1164.
PMID: 21804669BACKGROUNDGandotra K, May A, Auckley D. Variable Response to CPAP in a Case of Severe Obstructive Sleep Apnea: An Unusual Cause. J Clin Sleep Med. 2018 Jan 15;14(1):145-148. doi: 10.5664/jcsm.6904.
PMID: 29198296BACKGROUNDSafiruddin F, Koutsourelakis I, de Vries N. Analysis of the influence of head rotation during drug-induced sleep endoscopy in obstructive sleep apnea. Laryngoscope. 2014 Sep;124(9):2195-9. doi: 10.1002/lary.24598. Epub 2014 Mar 1.
PMID: 24431007BACKGROUNDSleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep. 1999 Aug 1;22(5):667-89. No abstract available.
PMID: 10450601BACKGROUNDOksenberg A, Silverberg D, Offenbach D, Arons E. Positional therapy for obstructive sleep apnea patients: A 6-month follow-up study. Laryngoscope. 2006 Nov;116(11):1995-2000. doi: 10.1097/01.mlg.0000237674.66716.a7.
PMID: 17075418BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Director of Operations
- Organization
- Sleep Systems
Study Officials
- PRINCIPAL INVESTIGATOR
Stacia Sailer, MD
Mass Lung and Allergy
- PRINCIPAL INVESTIGATOR
Payam Aghazzi, MD
Mass Lung and Allergy
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- Subject data is randomized to Investigator
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 29, 2019
First Posted
September 11, 2019
Study Start
November 28, 2016
Primary Completion
November 19, 2017
Study Completion
November 30, 2017
Last Updated
June 30, 2020
Results First Posted
June 30, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Data will be available immediately after publication. No end date
- Access Criteria
- Requesters will be required to sign a Data Access Agreement
De-identified individual and group subject data for all primary outcome measures will be made available